Astellas Pharma Inc
OTC:ALPMY

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
OTC:ALPMY
Watchlist
Price: 14.1 USD -0.84% Market Closed
Market Cap: 25.3B USD

Intrinsic Value

The intrinsic value of one ALPMY stock under the Base Case scenario is hidden USD. Compared to the current market price of 14.1 USD, Astellas Pharma Inc is hidden .

ALPMY Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Astellas Pharma Inc

Intrinsic Value History
Dive into the past to invest in the future

ALPMY looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ALPMY usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ALPMY?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ALPMY valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Astellas Pharma Inc.

Explain Valuation
Compare ALPMY to
Custom
Choose any stock to compare

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Astellas Pharma Inc?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Astellas Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALPMY Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

ALPMY Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score

Wall St
Price Targets

ALPMY Price Targets Summary
Astellas Pharma Inc

Wall Street analysts forecast ALPMY stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALPMY is 12.27 USD with a low forecast of 8.39 USD and a high forecast of 16.09 USD.

Lowest
Price Target
8.39 USD
41% Downside
Average
Price Target
12.27 USD
13% Downside
Highest
Price Target
16.09 USD
14% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Astellas Pharma Inc is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

ALPMY News

Other Videos
What is the Intrinsic Value of one ALPMY stock?

The intrinsic value of one ALPMY stock under the Base Case scenario is hidden USD.

Is ALPMY stock undervalued or overvalued?

Compared to the current market price of 14.1 USD, Astellas Pharma Inc is hidden .

Back to Top